Renaissance Technologies »

Silence Therapeutics shares owned by Renaissance Technologies

Quarter-by-quarter ownership of Silence Therapeutics (SLN) shares owned by Renaissance Technologies from 13F filings

Historical chart of Renaissance Technologies investment in Silence Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silence Therapeutics held by Renaissance Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silence Therapeutics by Renaissance Technologies

Quarter filed Position value Share count Share price at filing
2024-06-30 $743k 39k 19.00
2024-03-31 $2.2M 104k 21.60
2023-12-31 $471k 27k 17.38

More positions owned by Renaissance Technologies

Palantir Technologies Cl A (PLTR)
Novo-nordisk A S Adr (NVO)
United Therapeutics Corporation (UTHR)
Apple (AAPL)
Vertex Pharmaceuticals Incorporated (VRTX)
Microsoft Corporation (MSFT)
Verisign (VRSN)
Sprouts Fmrs Mkt (SFM)
Airbnb Com Cl A (ABNB)
NVIDIA Corporation (NVDA)
Exelixis (EXEL)
Franco-Nevada Corporation (FNV)
CBOE Holdings (CBOE)
Fortinet (FTNT)
Meta Platforms Cl A (META)

View all positions for Renaissance Technologies

Top funds holding Silence Therapeutics

TCG Crossover Management
Siren
Redmile Group
Logos Global Management
Deep Track Capital
Frazier Life Sciences Management
Nextech Invest
Henderson Group
Eventide Asset Management
Cormorant Asset Management
Ikarian Capital
5AM Venture Management
Point72 Asset Management
Citadel Advisors
Woodline Partners

View all funds holding Silence Therapeutics